Despite their potential, DNMT inhibitors face several challenges. One major issue is the development of resistance, where cancer cells adapt to the presence of the inhibitor and continue to proliferate. Furthermore, the off-target effects of DNMT inhibitors can lead to toxicity in normal cells, causing adverse side effects. Histological analysis is crucial in identifying these side effects and understanding the long-term impact of DNMT inhibition on tissues.
